Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis-1
- Christoph Stettler (95637)
- Sabin Allemann (95638)
- Simon Wandel (95639)
- Adnan Kastrati (95640)
- Marie Claude Morice (95641)
- Albert Schömig (95642)
- Matthias E Pfisterer (95643)
- Gregg W Stone (95644)
- Martin B Leon (95645)
- José Suárez de Lezo (95646)
- Jean-Jacques Goy (95647)
- Seung-Jung Park (95648)
- Manel Sabaté (95649)
- Maarten J Suttorp (95650)
- Henning Kelbaek (95651)
- Christian Spaulding (95652)
- Maurizio Menichelli (95653)
- Paul Vermeersch (95654)
- Maurits T Dirksen (95655)
- Pavel Cervinka (95656)
- Marco De Carlo (95657)
- Andrejs Erglis (95658)
- Tania Chechi (95659)
- Paolo Ortolani (95660)
- Martin J Schalij (95661)
- Peter Diem (95662)
- Bernhard Meier (95663)
- Stephan Windecker (95664)
- Peter Jüni (50488)
Publication date
December 2011
DOIAbstract
Sponding hazard ratios (95% credibility intervals) for three stent types estimated from network meta-analysis for pairwise comparisons in people with and without diabetes and restricted to trials with dual antiplatelet therapy of at least six months<p><b>Copyright information:</b></p><p>Taken from "Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis"</p><p></p><p>BMJ : British Medical Journal 2008;337():-.</p><p>Published online 29 Aug 2008</p><p>PMCID:PMC2527175.</p><p></p
Add to ORKG